Exploratory study for the efficacy and safety of Sansoninto on behavioral and psychological symptoms of dementia (BPSD) in patients with Dementia.: Multicenter trial

Exploratory study for the efficacy and safety of Sansoninto on behavioral and psychological symptoms of dementia (BPSD) in patients with Dementia.: Multicenter trial - The efficacy and safety of Sansoninto on behavioral and psychological symptoms of dementia (BPSD) in patients with Dementia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021562

Enrollment

Registered

2016-03-22

Start date

2016-03-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia patients with BPSD

Interventions

sansoninto for 4weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Diagnosed to be dementia 2) Within normal limit of serum potassium. 3) HDS-R under 20 4) Agreement to sign an informed consent.

Exclusion criteria

Exclusion criteria: 1) Patient who has an allergy to Sansoninto medicine. 2) Patients considered inappropriate by the study investigator.

Design outcomes

Primary

Measure	Time frame
Changes in neuropsychiatric inventory (NPI) score before and 4 weeks after sansonintotreatment	—

Secondary

Measure	Time frame
Changes in neuropsychiatric inventory (NPI) subscale before and 4 weeks after Sansoninto treatment	—

Countries

Japan

Contacts

Public ContactKazumi Hirata

Kanazawa University Hospital Department of Kampo Medicine

tomato.j2364832@gmail.com076-265-2918

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026